Literature DB >> 18515988

Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.

Stephanie S Liu1, Percy C K Tsang, Kelvin Y K Chan, Annie N Y Cheung, Karen K L Chan, Rebecca C Y Leung, Hextan Y S Ngan.   

Abstract

OBJECTIVES: The prevalent genotypes of human papillomavirus (HPV) infection and the significance of HPV16 integration in cervical precancerous lesions and cancer of Chinese women were investigated.
METHODS: HPV genotyping and HPV16 integration status were studied on 100 normal cervical cytology, 90 low-grade (LSIL) and 99 high-grade squamous intraepithelial lesions (HSIL), as well as 96 cervical cancer biopsies using DNA sequencing and quantitative real-time PCR.
RESULTS: HPV were detected in 12.0% of normal cytology, 93.3% of LSIL, 90.9% of HSIL and 89.6% of cervical cancer samples. High-risk HPV16, 18, 58, 52, 33 and 31 were the 6 major HPV types observed, composing 45.6, 82.8 and 85.4% of HPV infections in LSIL, HSIL and cervical cancers, respectively, with a significant rising trend in increasing disease severity (p = 0.002). While HPV16 and HPV18 were most commonly found in cervical cancer, HPV58 was prevalently observed in cervical precancerous lesions, and its frequency decreased with increased disease severity. Among HPV16-positive patients, 40.0% of LSIL, 88.9% of HSIL and 86.4% of cancer cases had HPV16 integration. The frequency of the integrated form of HPV16 significantly increased with the severity of the disease.
CONCLUSIONS: Our results demonstrated that high-risk HPV infection and viral DNA integration were in progressive frequency from low-grade cervical precancerous lesions to cancer. HPV16 integration status had the potential to be a marker for cancer risk assessment of cervical precancerous lesions. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18515988     DOI: 10.1159/000135690

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  4 in total

1.  Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay.

Authors:  Stephanie S Liu; Rebecca C Y Leung; Karen K L Chan; Annie N Y Cheung; Hextan Y S Ngan
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

2.  Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study.

Authors:  Donghong Zhang; Qingying Zhang; Li Zhou; Leijun Huo; Yi Zhang; Zhongying Shen; Yi Zhu
Journal:  BMC Cancer       Date:  2010-11-26       Impact factor: 4.430

3.  Multiple-integrations of HPV16 genome and altered transcription of viral oncogenes and cellular genes are associated with the development of cervical cancer.

Authors:  Xulian Lu; Qiaoai Lin; Mao Lin; Ping Duan; Lulu Ye; Jun Chen; Xiangmin Chen; Lifang Zhang; Xiangyang Xue
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

4.  Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis.

Authors:  Hui-Hui Xu; Kai Wang; Xing-Jun Feng; Shan-Shan Dong; Aifen Lin; Ling-Zhi Zheng; Wei-Hua Yan
Journal:  Oncotarget       Date:  2018-01-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.